TrialHaematologica2014

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.

Max Hubmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.